Synthesis and Inclusion Study of a Novel γ-Cyclodextrin Derivative as a Potential Thermo-Sensitive Carrier for Doxorubicin
-
- Xu Doudou
- Institute for Medical Science and Technology (IMSaT), College of Medicine, Dentistry and Nursing, University of Dundee
-
- Wang Lijun
- Institute for Medical Science and Technology (IMSaT), College of Medicine, Dentistry and Nursing, University of Dundee
-
- Gourevich Dana
- Institute for Medical Science and Technology (IMSaT), College of Medicine, Dentistry and Nursing, University of Dundee
-
- Kabha Eihab
- CapsuTech Ltd.
-
- Arditti Fabian
- CapsuTech Ltd.
-
- Athamna Muhammad
- CapsuTech Ltd.
-
- Cochran Sandy
- Institute for Medical Science and Technology (IMSaT), College of Medicine, Dentistry and Nursing, University of Dundee
-
- Melzer Andreas
- Institute for Medical Science and Technology (IMSaT), College of Medicine, Dentistry and Nursing, University of Dundee
-
- Gnaim Jallal Muhammad
- CapsuTech Ltd.
この論文をさがす
説明
A novel γ-cyclodextrin (γ-CD) based carrier for molecular encapsulation of cancer chemotherapeutic agent doxorubicin (DOX) was synthesized and fully characterized by various analytical approaches. The γ-CD derivative, with a β-naphthyl alanine residue attached in its primary face, exhibits potent binding capacity with DOX. The encapsulation efficiency was assessed under various temperatures and pHs and it was demonstrated that the carrier-DOX inclusion complex is highly stable under a wide range of acidic conditions (pH 1.0–7.0); however, the encapsulated drug is slowly released under hyperthermic conditions (up to 50°C). Cell culture studies showed that the complexation of DOX with the carrier protected the drug from being uptaken by the cells and also greatly reduced its toxicity. Thermo-triggered DOX release was validated and the increase in cellular uptake was observed in in-vitro experiments. We concluded that this novel γ-CD derivative is able to effectively encapsulate DOX and the inclusion is responsive to temperature change, hence renders it a potential encapsulating agent for DOX delivery in combination with hyperthermia treatments.
収録刊行物
-
- CHEMICAL & PHARMACEUTICAL BULLETIN
-
CHEMICAL & PHARMACEUTICAL BULLETIN 62 (7), 627-635, 2014
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679153409024
-
- NII論文ID
- 130004053810
-
- NII書誌ID
- AA00602100
-
- COI
- 1:STN:280:DC%2BC2cfovFSluw%3D%3D
-
- ISSN
- 13475223
- 00092363
-
- NDL書誌ID
- 025543011
-
- PubMed
- 24990500
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可